West Pharmaceutical Services share price today
(NASDAQ: WST)

Name: West Pharmaceutical Services Share Price Today (NASDAQ: WST) - West Pharmaceutical Services Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

West Pharmaceutical Services share price is $343.99 & ₹29,751.70 as on 24 Jan 2025, 2.30 'hrs' IST

$343.99

▲

-3.88

(-1.12%)

Market is closed - opens 8 PM, 24 Jan 2025

View live West Pharmaceutical Services share price in Dollar and Rupees. Guide to invest in West Pharmaceutical Services stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in West Pharmaceutical Services, along with analyst recommendations, forecasts, and comprehensive financials.

West Pharmaceutical Services share price movements

Today's Low: $335.91
Today's High: $345.31
$343.99
2.35%
Downside
Day's Volatility :2.72%
Upside
0.38%
52 Weeks Low: $265.00
52 Weeks High: $413.70
$343.99
22.96%
Downside
52 Weeks Volatility :35.94%
Upside
16.85%

West Pharmaceutical Services Returns

Period	West Pharmaceutical Services Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	12.97%	-4.8%	0.0%
6 Months	22.16%	-5.1%	0.0%
1 Year	-1.79%	2.5%	0.0%
3 Years	-8.06%	10.2%	-13.0%

West Pharmaceutical Services Key Statistics

in dollars & INR

Previous Close	$347.87
Open	$347.88
Today's High	$345.305
Today's Low	$335.905
Market Capitalization	$25.0B
Today's Volume	$386.6K
52 Week High	$413.7
52 Week Low	$265.0
Revenue TTM	$2.9B
EBITDA	$744.7M
Earnings Per Share (EPS)	$6.73
PE Ratio	51.22
Dividend Yield	0.25%
Profit Margin	17.37%
Quarterly Earnings Growth YOY	-0.14%
Return On Equity TTM	17.78%

How to invest in West Pharmaceutical Services Stock (WST) from India?

It is very easy for Indian residents to invest directly in West Pharmaceutical Services from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the West Pharmaceutical Services stock in both Indian Rupees (INR) and US Dollars (USD). Search for West Pharmaceutical Services or WST on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of West Pharmaceutical Services or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of West Pharmaceutical Services shares which would translate to 0.003 fractional shares of West Pharmaceutical Services as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like West Pharmaceutical Services, in just a few clicks!

Returns in West Pharmaceutical Services for Indian investors in Rupees

Investment Value

₹1,00,000

West Pharmaceutical Services investment value today

Current value as on today

₹1,01,221

Returns

₹1,221

(+1.22%)

Returns from West Pharmaceutical Services Stock

₹2,888 (-2.89%)

Dollar Returns

₹4,109 (+4.11%)

Indian investors sentiment towards West Pharmaceutical Services

-30%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for West Pharmaceutical Services on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -30% less investors are searching West Pharmaceutical Services in the last 30 days versus the previous period.

Indian Mutual Funds that invest in West Pharmaceutical Services

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	625	-0.19	0.05%
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	14000	-	1.22%

Global Institutional Holdings in West Pharmaceutical Services

Vanguard Group Inc
12.41%
BlackRock Inc
10.05%
Bank of New York Mellon Corp
4.48%
State Street Corp
4.44%
Artisan Partners Limited Partnership
4.23%
AllianceBernstein L.P.
3.59%

Analyst Recommendation on West Pharmaceutical Services

Buy

69%Buy

30%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for West Pharmaceutical Services(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on West Pharmaceutical Services

What analysts predicted

Upside of 10.42%

Target:

$379.85

Current:

$343.99

Insights on West Pharmaceutical Services

Price Movement
In the last 7 days, WST stock has moved up by 3.4%
Increasing Revenue
West Pharmaceutical Services Inc has shown a positive revenue trend over the last three quarters. Revenue has increased from $695.4 million to $746.9 million, reflecting an average growth of 3.5% per quarter.
Increasing Net Profit
West Pharmaceutical Services Inc has shown a positive trend in its net profit over the last two quarters. The net profit increased from $111.3 million to $136.0 million, reflecting an average growth of 18.2% per quarter.
WST vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 65.0% return, outperforming this stock by 65.2%
WST vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 124.4% return, outperforming this stock by 133.7%
Price to Sales
West Pharmaceutical Services Inc has a Price-to-Sales Ratio of 8.8. This means that for every $1 of sales the company generates, investors are willing to pay $8.8. In comparison, investors are willing to pay $27.4 for every $1 of sales for Intuitive Surgical, Inc. This indicates that West Pharmaceutical's shares are less expensive relative to its sales compared to Intuitive Surgical.

West Pharmaceutical Services Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.7B	↑ 7.4%
Net Income	$206.9M	↑ 37.29%
Net Profit Margin	12.05%	↑ 2.63%

	FY19	Y/Y Change
Revenue	$1.8B	↑ 7.13%
Net Income	$241.7M	↑ 16.82%
Net Profit Margin	13.14%	↑ 1.09%

	FY20	Y/Y Change
Revenue	$2.1B	↑ 16.69%
Net Income	$346.2M	↑ 43.24%
Net Profit Margin	16.13%	↑ 2.99%

	FY21	Y/Y Change
Revenue	$2.8B	↑ 31.89%
Net Income	$661.8M	↑ 91.16%
Net Profit Margin	23.37%	↑ 7.24%

	FY22	Y/Y Change
Revenue	$2.9B	↑ 1.95%
Net Income	$585.9M	↓ 11.47%
Net Profit Margin	20.3%	↓ 3.07%

	FY23	Y/Y Change
Revenue	$2.9B	↑ 2.18%
Net Income	$593.4M	↑ 1.28%
Net Profit Margin	20.12%	↓ 0.18%

	Q2 FY23	Q/Q Change
Revenue	$753.8M	↑ 5.19%
Net Income	$155.1M	↑ 10.79%
Net Profit Margin	20.58%	↑ 1.04%

	Q3 FY23	Q/Q Change
Revenue	$747.4M	↓ 0.85%
Net Income	$161.3M	↑ 4.0%
Net Profit Margin	21.58%	↑ 1.0%

	Q4 FY23	Q/Q Change
Revenue	$732.0M	↓ 2.06%
Net Income	$137.0M	↓ 15.07%
Net Profit Margin	18.72%	↓ 2.86%

	Q1 FY24	Q/Q Change
Revenue	$695.4M	↓ 5.0%
Net Income	$115.3M	↓ 15.84%
Net Profit Margin	16.58%	↓ 2.14%

	Q2 FY24	Q/Q Change
Revenue	$702.0M	↑ 0.95%
Net Income	$111.3M	↓ 3.47%
Net Profit Margin	15.85%	↓ 0.73%

	Q3 FY24	Q/Q Change
Revenue	$746.9M	↑ 6.4%
Net Income	$136.0M	↑ 22.19%
Net Profit Margin	18.21%	↑ 2.36%

	FY18	Y/Y Change
Profit	$545.4M	↑ 6.4%

	FY19	Y/Y Change
Profit	$605.7M	↑ 11.06%

	FY20	Y/Y Change
Profit	$767.8M	↑ 26.76%

	FY21	Y/Y Change
Profit	$1.2B	↑ 53.14%

	FY22	Y/Y Change
Profit	$1.1B	↓ 3.37%

	FY23	Y/Y Change
Profit	$1.1B	↓ 0.62%

	Q2 FY23	Q/Q Change
Profit	$291.4M	↑ 7.41%

	Q3 FY23	Q/Q Change
Profit	$288.3M	↓ 1.06%

	Q4 FY23	Q/Q Change
Profit	$278.2M	↓ 3.5%

	Q1 FY24	Q/Q Change
Profit	$230.2M	↓ 17.25%

	Q2 FY24	Q/Q Change
Profit	$231.3M	↑ 0.48%

	Q3 FY24	Q/Q Change
Profit	$264.7M	↑ 14.44%

	FY18	Y/Y Change
Operating Cash Flow	$288.6M	↑ 9.61%
Investing Cash Flow	$-100.8M	↓ 24.55%
Financing Cash Flow	$-80.7M	↓ 25.96%

	FY19	Y/Y Change
Operating Cash Flow	$367.2M	↑ 27.23%
Investing Cash Flow	$-228.0M	↑ 126.19%
Financing Cash Flow	$-36.8M	↓ 54.4%

	FY20	Y/Y Change
Operating Cash Flow	$472.5M	↑ 28.68%
Investing Cash Flow	$-179.5M	↓ 21.27%
Financing Cash Flow	$-137.1M	↑ 272.55%

	FY21	Y/Y Change
Operating Cash Flow	$584.0M	↑ 23.6%
Investing Cash Flow	$-253.1M	↑ 41.0%
Financing Cash Flow	$-168.1M	↑ 22.61%

	FY22	Y/Y Change
Operating Cash Flow	$724.0M	↑ 23.97%
Investing Cash Flow	$-288.2M	↑ 13.87%
Financing Cash Flow	$-293.6M	↑ 74.66%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$169.2M	↑ 22.52%
Investing Cash Flow	$-82.1M	↑ 0.0%
Financing Cash Flow	$-176.8M	↑ 149.01%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$230.1M	↑ 35.99%
Investing Cash Flow	$-259.9M	↑ 216.57%
Financing Cash Flow	$-22.3M	↓ 87.39%

West Pharmaceutical Services Technicals Summary

Sell

Neutral

Buy

West Pharmaceutical Services is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

West Pharmaceutical Services Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
West Pharmaceutical Services Inc	4.33%	22.16%	-1.79%	-8.06%	123.72%
Intuitive Surgical, Inc.	13.29%	38.33%	62.8%	131.11%	222.7%
Alcon Ag	2.87%	-4.92%	16.36%	19.6%	45.42%
Resmed Inc.	5.75%	25.52%	32.72%	6.53%	53.98%
Becton, Dickinson And Company	4.3%	0.26%	0.57%	-7.82%	-14.95%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
West Pharmaceutical Services Inc	51.22	51.22	6.28	6.63	0.18	0.1	0.0	37.96
Intuitive Surgical, Inc.	97.13	97.13	4.38	6.92	0.16	0.08	NA	43.75
Alcon Ag	37.84	37.84	3.21	3.03	0.06	0.03	0.0	43.25
Resmed Inc.	32.91	32.91	1.82	9.35	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	40.67	40.67	1.09	14.35	0.06	0.03	0.02	89.47

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
West Pharmaceutical Services Inc	Buy	$25.0B	123.72%	51.22	17.37%
Intuitive Surgical, Inc.	Buy	$215.2B	222.7%	97.13	28.51%
Alcon Ag	Buy	$44.2B	45.42%	37.84	11.89%
Resmed Inc.	Buy	$36.4B	53.98%	32.91	23.15%
Becton, Dickinson And Company	Buy	$69.0B	-14.95%	40.67	7.13%

West Pharmaceutical Services Dividend announcements

West Pharmaceutical Services Dividends December, 2024
In the quarter ending December,2024. West Pharmaceutical Services has declared dividend of $0.21
Read More

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Organization	West Pharmaceutical Services
Employees	10600
CEO	Mr. Eric M. Green
Industry	Health Technology

Management People of West Pharmaceutical Services

Name	Title
Mr. Eric M. Green	Non-Independent Chair of the Board, President & CEO
Mr. Bernard J. Birkett	Senior VP & CFO
Ms. Kimberly Banks MacKay	Senior VP, General Counsel & Company Secretary
Ms. Cindy Reiss-Clark	Senior VP & Chief Commercial Officer
Mr. Chad R. Winters	VP, Chief Accounting Officer & Corporate Controller
Mr. John P. Sweeney C.F.A.	Head of Investor Relations
Michele Polinsky	Vice President of Global Communications
Mr. Rudy Poussot	Senior VP of Strategy & Corporate Development
Ms. Annette F. Favorite	Chief Human Resources Officer & Senior VP
Ms. Kathy DePadua	Senior VP and Chief Quality & Regulatory Officer

Important FAQs about investing in West Pharmaceutical Services (WST) from India :

What is West Pharmaceutical Services share price today?

West Pharmaceutical Services share price today stands at $343.99, Open: $347.88 ; Previous Close: $347.87 ; High: $345.31 ; Low: $335.91 ; 52 Week High: $413.70 ; 52 Week Low: $265.00. The stock opens at $347.88, after a previous close of $347.87. The stock reached a daily high of $345.31 and a low of $335.91, with a 52-week high of $413.70 and a 52-week low of $265.00.

Can Indians buy West Pharmaceutical Services shares?

Yes, Indians can invest in the West Pharmaceutical Services (WST) from India.

With INDmoney, you can buy West Pharmaceutical Services at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy West Pharmaceutical Services at zero transaction cost.

How can I buy West Pharmaceutical Services shares from India?

It is very easy to buy West Pharmaceutical Services from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of West Pharmaceutical Services be purchased?

Yes, you can buy fractional shares of West Pharmaceutical Services with INDmoney app.

What are the documents required to start investing in West Pharmaceutical Services stocks?

To start investing in West Pharmaceutical Services, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.